Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Indications & Uses
Oracal is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
250 mg or 500 mg tablet: Calcium Carbonate is always taken by mouth. When it is used as an antacid, the recommended dose for adults ranges from 540 mg to 2000 mg of Calcium Carbonate per day, with children given half the adult dose. As a dietary supplement, such as for preventing osteoporosis, the general recommendation is 1250 mg to 3750 mg of Calcium Carbonate (500 mg to 1500 mg of calcium) daily, though this should be tailored to the individual patient depending on any specific condition such as calcium deficiency, malabsorption, or parathyroid problems. During pregnancy and breastfeeding, the recommended daily dose of calcium is 1200 mg to 1500 mg. In chronic renal failure, doses of Calcium Carbonate used range from 2.5 gm to 9.0 gm per day and need to be adjusted for the individual patient. To get the most effective phosphate binding in this situation, Calcium Carbonate should be taken with meals. 1000 mg tablet: 2000 mg to 3000 mg when symptoms occur; this may be repeated hourly if needed, or as directed by the physician.
Side Effects
Orally administered Forbon may irritate the gastrointestinal tract and can lead to constipation. Calcium taken alone rarely causes hypercalcaemia, though this may occur when high doses are given to patients with chronic renal failure.
Cautions & Contraindications
Contraindications
Hypercalcaemia and hyperparathyroidism, hypercalciuria and nephrolithiasis, and Zollinger-Ellison syndrome are contraindications. Concomitant use with digoxin requires careful monitoring of serum calcium levels. When hypercalcaemia occurs, stopping the drug is usually enough to bring serum calcium concentrations back to normal. Calcium salts should be used cautiously in patients with sarcoidosis, renal or cardiac disease, and in those receiving cardiac glycosides.